Bayesian Classification of Clinical Practice Guidelines

被引:0
作者
Diamond, George A. [1 ,3 ,4 ]
Kaul, Sanjay [1 ,2 ]
机构
[1] Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA USA
[2] Univ Calif Los Angeles, Cedars Sinai Heart Inst, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
关键词
IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; DILATED CARDIOMYOPATHY; HEALTH-CARE; PREVENTION; AMIODARONE; THERAPY; TRIAL;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clinical practice guidelines are generally constructed from an admixture of expert consensus opinion, case-control studies, and randomized controlled trials (RCTs) and are categorized according to the methodological quality of the underlying data (level of evidence) and the trade-off between the benefits and risks of treatment (class of recommendation). The process is driven principally by conventional statistical significance and does not specifically consider the clinical importance of the alternative treatment effects. We herein propose a more formal quantitative algorithm for the construction of guidelines using Bayes's theorem to integrate the clinical trial evidence with a range of prior belief representing the skeptical point of view embodied in the null hypothesis (to the effect that treatment can be expected to produce no reduction in risk), and the enthusiastic point of view embodied in the alternative hypothesis (to the effect that treatment can be expected to produce a specified clinically important reduction in risk). The operative practical utility of this algorithm is illustrated by application to a representative meta-analysis of RCTs. We conclude that this quantitative schema has the potential to improve the quality and cost of evidence-based clinical management. Arch Intern Med. 2009; 169(15):1431-1435
引用
收藏
页码:1431 / 1435
页数:5
相关论文
共 23 条
[1]  
[Anonymous], BURDEN PROOF
[2]   Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy -: The cardiomyopathy trial (CAT) [J].
Bänsch, D ;
Antz, M ;
Boczor, S ;
Volkmer, M ;
Tebbenjohanns, J ;
Seidl, K ;
Block, M ;
Gietzen, F ;
Berger, J ;
Kuck, KH .
CIRCULATION, 2002, 105 (12) :1453-1458
[3]   Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].
Bardy, GH ;
Lee, KL ;
Mark, DB ;
Poole, JE ;
Packer, DL ;
Boineau, R ;
Domanski, M ;
Troutman, C ;
Anderson, J ;
Johnson, G ;
McNulty, SE ;
Clapp-Channing, N ;
Davidson-Ray, LD ;
Fraulo, ES ;
Fishbein, DP ;
Luceri, RM ;
Ip, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237
[4]   ACC/AHA Classification of Care Metrics: Performance Measures and Quality Metrics A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures [J].
Bonow, Robert O. ;
Masoudi, Frederick A. ;
Rumsfeld, John S. ;
DeLong, Elizabeth ;
Estes, A. Mark, III ;
Goff, David C., Jr. ;
Grady, Kathleen ;
Green, Lee A. ;
Loth, Ann R. ;
Peterson, Eric D. ;
Pina, Ileana L. ;
Radford, Martha J. ;
Shahian, David M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (24) :2113-2117
[5]   Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure [J].
Bristow, MR ;
Saxon, LA ;
Boehmer, J ;
Krueger, S ;
Kass, DA ;
De Marco, T ;
Carson, P ;
DiCarlo, L ;
DeMets, D ;
White, BG ;
DeVries, DW ;
Feldman, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2140-2150
[6]  
DASTON L, 1988, CLASSICAL PROBABILIT, P33
[7]   Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy - A meta-analysis of randomized controlled trials [J].
Desai, AS ;
Fang, JC ;
Maisel, WH ;
Baughman, KL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (23) :2874-2879
[8]   Prior convictions - Bayesian approaches to the analysis and interpretation of clinical megatrials [J].
Diamond, GA ;
Kaul, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (11) :1929-1939
[9]   Evidence-Based Financial Incentives for Healthcare Reform Putting It Together [J].
Diamond, George A. ;
Kaul, Sanjay .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (02) :134-140
[10]  
FEINSTEIN AR, 1985, CLIN EPIDEMIOLOGY AR, P118